CA992461A - Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol - Google Patents

Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol

Info

Publication number
CA992461A
CA992461A CA148,628A CA148628A CA992461A CA 992461 A CA992461 A CA 992461A CA 148628 A CA148628 A CA 148628A CA 992461 A CA992461 A CA 992461A
Authority
CA
Canada
Prior art keywords
carboxychromon
yloxy
propan
bis
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA148,628A
Other languages
English (en)
Other versions
CA148628S (en
Inventor
Donald R. Macarthur
David E. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA992461(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of CA992461A publication Critical patent/CA992461A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA148,628A 1971-08-10 1972-08-03 Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol Expired CA992461A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (1)

Publication Number Publication Date
CA992461A true CA992461A (en) 1976-07-06

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA148,628A Expired CA992461A (en) 1971-08-10 1972-08-03 Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol

Country Status (19)

Country Link
US (1) US4009280A (index.php)
JP (1) JPS5652001B2 (index.php)
AT (1) AT333974B (index.php)
AU (1) AU5119173A (index.php)
CA (1) CA992461A (index.php)
DE (1) DE2239091A1 (index.php)
DK (2) DK131891C (index.php)
ES (1) ES410910A1 (index.php)
FI (1) FI56487C (index.php)
FR (1) FR2150759B1 (index.php)
GB (1) GB1410588A (index.php)
IE (1) IE37102B1 (index.php)
IL (1) IL39990A (index.php)
LU (1) LU66875A1 (index.php)
NL (1) NL7210780A (index.php)
NO (1) NO140747C (index.php)
SE (1) SE411842B (index.php)
ZA (1) ZA73284B (index.php)
ZM (1) ZM11971A1 (index.php)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042826A (index.php) * 1973-08-20 1975-04-18
JPS5042827A (index.php) * 1973-08-20 1975-04-18
JPS5042819A (index.php) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (index.php) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
EA003665B1 (ru) † 1997-09-29 2003-08-28 Нектар Терапьютикс Перфорированные микрочастицы и способ их использования
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
PL365736A1 (en) * 2001-02-06 2005-01-10 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2415654T3 (es) * 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
WO2010010538A2 (en) * 2008-07-24 2010-01-28 L'air Liquide-Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS4826764A (index.php) 1973-04-09
AU5119173A (en) 1974-07-18
FI56487B (fi) 1979-10-31
GB1410588A (en) 1975-10-22
DK146974C (da) 1984-08-13
DK131891B (da) 1975-09-22
NO140747B (no) 1979-07-30
FR2150759B1 (index.php) 1975-10-31
US4009280A (en) 1977-02-22
NL7210780A (index.php) 1973-02-13
ES410910A1 (es) 1976-07-16
DK131891C (da) 1976-02-23
DK535774A (index.php) 1975-06-02
JPS5652001B2 (index.php) 1981-12-09
LU66875A1 (index.php) 1973-03-23
FI56487C (fi) 1980-02-11
ATA39073A (de) 1976-04-15
IL39990A0 (en) 1972-09-28
ZA73284B (en) 1973-11-28
NO140747C (no) 1979-11-07
IL39990A (en) 1977-02-28
FR2150759A1 (index.php) 1973-04-13
IE37102B1 (en) 1977-05-11
AT333974B (de) 1976-12-27
ZM11971A1 (en) 1973-02-21
DK146974B (da) 1984-03-05
SE411842B (sv) 1980-02-11
DE2239091A1 (de) 1973-02-22

Similar Documents

Publication Publication Date Title
CA992461A (en) Inhalation composition containing micronized 1,3-bis(2-carboxychromon-5-yloxy) propan-2-ol
AU502164B2 (en) Pharmaceutical composition containing 2, 6-diisopropylphenol
CA970685A (en) Composition containing inhalation medicaments
IL38342A (en) Bis(3,5-dixopiperazin-1-yl)alkane compounds and pharmaceutical compositions containing them
CA919193A (en) Preparation of 3,3',5,5'-tetra-isopropyl-4,4'-hydroxydiphenyl
CA992538A (en) 2-phenyl-as-triazine-3,5(2h,4h)diones and derivatives thereof and compositions containing said compounds
CA1000201A (en) Compositions containing 1,3-bis (2-carboxychromon-5-yloxy)-propan-2-ol, or 5,5'-(2-hydroxytrimethylene)dloxy)bis(4-oxo-4h-1-benzopyran-2-yl))tetrazole
IL49964A0 (en) 4-imino-1,3-diazobicyclo(3.1.0)hexan-2-one,processes for the preparation thereof and pharmaceutical compositions containing the same
IL40572A (en) 4-(2'-fluoro-4-biphenylyl)-1-butanol,processes for its preparation and pharmaceutical compositions containing it
AU465875B2 (en) Local anesthetic compositions
IL39126A0 (en) Novel benzofuran derivatives,their manufacture and pharmaceutical compositions containing them
IL39889A0 (en) Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof
AU3695971A (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
IL49344A (en) 2-substituted-7-halo-1,8-maphthyridine compounds,processesfor preparing the same and pharmaceutical compositions containing the same
AU463573B2 (en) Trialkylsilyl ethers of 11-alkyl-17-alkynylestra-1, 3, 5(10)-trien-3, 17-diols
CA971481A (en) Pharmaceutical compositions containing benzofuran derivatives
CA864527A (en) Aerosol antiperspirant composition
CA963389A (en) Stabilized blood composition
IL40639A0 (en) Novel nitrofuran derivatives,processes for their preparation and pharmaceutical compositions containing the same
CA869978A (en) Therapeutic compositions containing 4,5,6,7-tetrahydro-4-oxoindoles
CA1000283A (en) Amino-indazole compounds, processes for making them and pharmaceutical compositions containing them
CA983859A (en) Aerosol antiperspirant composition
CA886557A (en) Pure 2,3,6-trimethylphenol
CA838088A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE
CA873314A (en) Anaesthetic compositions